CLOs on the Move

United Allergy Labs

www.unitedallergylabs.com

 
United Allergy Labs is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Enara Health

Enara Health is building a data-driven platform and network to scale obesity treatment. Based in San Mateo, Calif., and operating since March 2015, Enara Health offers unique hybrid digital and in-person weight loss programs based on precision medicine. By combining mobile technology with health care visits and providing patients with personalized physician-driven medical weight loss programs, Enara Health routinely helps patients lose—and keep off—more than 15% of their baseline weight, which is far greater than the results seen with other m-health interventions.

Cornerstone Therapeutics, Inc.

Cornerstone Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Cary, NC. To find more information about Cornerstone Therapeutics, Inc., please visit www.crtx.com

Slumber Sleep Aid

Struggling with sleep issues? Try CBN for sleep! Slumber Sleep Aid offers variations of plant-based CBD and CBN products for sleep.

quip

Quip is the oral care company designing and delivering products, advice and professional services to make oral health more simple, accessible, and enjoyable.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.